Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories / Photo: Michael M. Santiago - GETTY IMAGES NORTH AMERICA/AFP/File
-
US envoys in Moscow as Russia and Ukraine vow not to hit capitals during talks
-
US military says destroys Iranian oil tankers after missile attacks
-
Motorsport governing body rejects Alpine boss's claims of bias
-
US envoys in Moscow for Ukraine war negotiations
-
US envoy on West Bank visit says Israel has responsibility for Palestinians
-
Commemoration held for late Serbian war criminal Ratko Mladic
-
Ethiopian Miss World contestant spotlights pain of sister's murder
-
Russell on top ahead of Hamilton in final Italian GP practice
-
'Leader' Raphinha rising to Barca striker challenge
-
Motorsport governing body rejects Alpine boss's claims of impartiality
-
Oasis fans gather in Venice for band reunion film
-
Flick hoping Barca's Yamal can face Valencia after knock
-
Two Nepal rescues revive hopes 10 days after flood
-
Trump envoys land in Moscow for Russia-Ukraine peace push
-
Pogacar to miss worlds after season-ending Vuelta crash
-
Russia hits Kyiv airports as Trump peace envoys awaited
-
Greenwood, Guendouzi handed bans after Fenerbahce-Lyon brawl
-
Nepal tunnel rescue revives hopes 10 days after flood
-
In Iceland, the mystery of the poet, the tomb and the Danish grocer
-
Indonesia rescues second orangutan mother and baby from wildfire
-
Ratko Mladic: Bosnian Serb commander to convicted war criminal
-
Box office magnet Robert Pattinson appears in paedophile thriller
-
Bolivian army base blasts kill two, wound dozens
-
How haze from Indonesian fires impacts Southeast Asia
-
Alcaraz, Sabalenka into US Open last 16 as Williams sisters lose on return
-
Trump sends envoys to Moscow, Kyiv with new plan to 'end war'
-
Williams sisters fall in thrilling return to US Open doubles
-
'Mini-dictatorship': Students slam Argentina-run residence in Paris
-
Bangladesh measles toll nears grim 1,000-child mark
-
The disgraced banker stirring the pot in Brazil's Supreme Court
-
Bolivia farmers return to streets over diesel price hikes
-
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST)
-
Panama Canal begins reducing crossings due to El Nino
-
Tetris distances itself from controversial White House 'arcade' games
-
Trump again seeks to remove protections for wolves
-
Africa bigger, US smaller - UN adopts new map
-
'Getting there' - Alcaraz into US Open last 16 along with Sabalenka
-
Bad weather will not affect All Blacks, says captain Savea
-
Isak ready to show world his quality, says Van Dijk
-
Mbappe misses penalty as Parrott lifts Betis past Real Madrid
-
Stuttgart cruise past Cologne to bounce back from Bayern thumping
-
PSG still winless in Ligue 1 as Monaco go top
-
'Smart, aggressive' Alcaraz into US Open last 16
-
Defending champion Alcaraz reaches last 16 at US Open
-
Isak fires Liverpool to first win under Iraola at Ipswich
-
Lyles ends season before Budapest due to injury flare ups
-
Stocks slip as robust US jobs data stokes rate hike odds
-
US Republicans announce probe into environment groups
-
Mistrial declared in case of US woman who killed her three children
-
Sabalenka survives despite 'tricky' weed smell at US Open
Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories
US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the United States in a committment designed to influence upcoming Trump administration decisions on trade and other issues.
The drugmaker, which is in growth mode thanks partly to the success of anti-obesity drugs Zepbound and Mounjaro, expects to add more than 3,000 jobs at the four sites as it committed to tens of billions of dollars in additional investment.
Chief Executive David Ricks said in a statement the boosted capital spending underscores the company's "optimism about the potential of our pipeline" and determination to "stay ahead of anticipated demand for safe, high-quality, FDA-approved medicines of the future."
The move, announced at a Washington news conference, comes as Trump proceeds with a deluge of tariff actions and proposed tax cut extensions designed to incentivize global companies to invest in the United States. Trump's administration is also undertaking deep job cuts across the US regulatory universe that could affect such processes as the application for new drugs.
The company's press release described Trump's 2017 corporate tax cut as "foundational to Lilly's domestic manufacturing investments," adding that "it is essential that these policies are extended this year."
In an interview with CNBC, Ricks said he would call on the Trump administration to address lengthy permitting times to build new facilities due to onerous requirements of the US Food and Drug Administration.
Ricks also aims to influence the "contours" of Trump's trade policy, saying "it makes no sense to punish companies that are pursuing this agenda with the administration and on behalf of the American people."
Wednesday's announcement will raise Lilly's domestic capital expansion commitment to $50 billion from $23 billion previously committed between 2020 and 2024 to construct or expand sites in the states of North Carolina, Indiana and Wisconsin.
The company is "currently in negotiations with several states and welcomes additional interest by March 12, 2025," said a press release that included a link to express interest online.
Shares of Lilly rose 1.7 percent shortly after midday.
O.Brown--AT
